Skip to main content

Table 8 Changes in intermediate patient outcomes°

From: Effectiveness of the introduction of a Chronic Care Model-based program for type 2 diabetes in Belgium

  Intervention period Δ
01/01/04-01/01/07
P value*
  01/01/2004 01/01/2007   
HbA1c (%)     
   Intervention 7.55(7.48-7.62) 7.06(7.00-7.12) -0.49(p < 0.0001) 0.4207
   Control 7.44(7.34-7.53) 6.90(6.83-6.98) -0.54(p < 0.0001)  
TC (mg/dl)     
   Intervention 199.07(197.01-201.13) 173.94(171.85-176.04) -25.13(p < 0.0001) 0.0021 (1)
   Control 199.44(197.03-201.90) 180.60(177.83-183.41) -18.84(p < 0.0001)  
  1. °linear mixed model; Δ = evolution; *P value for the evolution between the intervention and control region, (1) significantly greater change in the intervention region (2) significantly greater change in the control region